Loading...
Presenters at this year's meeting of the American Society of Clinical Oncology (ASCO), held virtually June 4–8, 2021, discussed the latest cancer research. Associate Editor Michael E. Williams, MD, ScM, describes the key findings in malignant hematology. Meeting abstracts can be viewed in the ASCO meeting library.
Combined chemotherapy plus consolidative radiation therapy (RT) has been an established standard of care for Hodgkin lymphoma (HL) with mediastinal mass >10 cm or larger than one third of the chest diameter. In a U.S. multicenter trial, 94 patients with stage I–II bulky HL received two cycles of doxorubicin-bleomycin-vinblastine-dacarbazine (ABVD) followed by positron emission tom…